• Real Time Chart Real Time Chart
  • Stock Profile Stock Profile
  • Financials As Reported

    • accession Number 0000950170-23-017724
    • accounts Payable Current 9,453,000
    • accumulated Other Comprehensive Income Loss Net Of Tax 843,000
    • allocated Share Based Compensation Expense 3,050,000
    • amendment Flag false
    • assets 154,593,000
    • assets Current 146,057,000
    • cash And Cash Equivalents At Carrying Value 105,765,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 105,915,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 10,132,000
    • cik 1,314,102
    • city Area Code (617)
    • common Stock Par Or Stated Value Per Share 0.001
    • common Stock Shares Authorized 300,000,000
    • common Stock Shares Issued 34,301,926
    • common Stock Shares Outstanding 34,301,926
    • comprehensive Income Net Of Tax --21,107,000
    • current Fiscal Year End Date --12-31
    • date Filed 2023-05-04
    • depreciation 105,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic -0.56
    • earnings Per Share Diluted -0.56
    • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized 11,900,000
    • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 P1Y8M12D
    • entity Address Address Line 1 480 Pleasant Street
    • entity Address City Or Town Watertown
    • entity Address Postal Zip Code 2,472
    • entity Address State Or Province MA
    • entity Central Index Key 1,314,102
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 000-51122
    • entity Filer Category Non-accelerated Filer
    • entity Incorporation State Country Code DE
    • entity Interactive Data Current Yes
    • entity Name EyePoint Pharmaceuticals, Inc.
    • entity Registrant Name EyePoint Pharmaceuticals, Inc.
    • entity Shell Company false
    • entity Small Business true
    • entity Tax Identification Number 26-2774444
    • increase Decrease In Contract With Customer Liability --255,000
    • increase Decrease In Inventories 1,185,000
    • interest Expense 812,000
    • interest Paid Net 740,000
    • inventory Net 4,071,000
    • irs Number 262,774,444
    • lessee Operating Lease Liability Payments Due 7,570,000
    • lessee Operating Lease Liability Payments Due Next Twelve Months 1,392,000
    • lessee Operating Lease Liability Payments Due Year Four 1,637,000
    • lessee Operating Lease Liability Payments Due Year Three 1,589,000
    • lessee Operating Lease Liability Payments Due Year Two 1,494,000
    • lessee Operating Lease Liability Undiscounted Excess Amount 1,095,000
    • liabilities 76,203,000
    • liabilities And Stockholders Equity 154,593,000
    • liabilities Current 27,242,000
    • local Phone Number 926-5000
    • long Term Debt Maturities Repayments Of Principal In Next Twelve Months 9,167,000
    • long Term Debt Maturities Repayments Of Principal In Year Four 833,000
    • long Term Debt Maturities Repayments Of Principal In Year Three 10,000,000
    • long Term Debt Maturities Repayments Of Principal In Year Two 10,000,000
    • long Term Debt Noncurrent 29,370,000
    • marketable Securities Current 16,700,000
    • net Cash Provided By Used In Financing Activities --5,119,000
    • net Cash Provided By Used In Investing Activities 32,086,000
    • net Cash Provided By Used In Operating Activities --16,835,000
    • net Income Loss --21,164,000
    • nonoperating Income Expense 390,000
    • operating Expenses 29,237,000
    • operating Income Loss --21,554,000
    • operating Lease Liability 6,475,000
    • operating Lease Liability Current 754,000
    • operating Lease Liability Current Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
    • operating Lease Liability Noncurrent 5,721,000
    • operating Lease Payments 145,000
    • operating Lease Right Of Use Asset 5,777,000
    • other Assets Current 0
    • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 57,000
    • other Liabilities Current 772,000
    • other Liabilities Noncurrent 600,000
    • other Nonoperating Income Expense 1,202,000
    • payments Related To Tax Withholding For Share Based Compensation 169,000
    • payments To Acquire Property Plant And Equipment 484,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • proceeds From Issuance Of Long Term Debt 0
    • property Plant And Equipment Net 2,609,000
    • repayments Of Long Term Debt 0
    • report Link https://www.sec.gov/Archives/edgar/data/1314102/000095017023017724/eypt-20230331_htm.xml
    • research And Development Expense 13,618,000
    • retained Earnings Accumulated Deficit --692,515,000
    • revenue From Contract With Customer Excluding Assessed Tax 7,683,000
    • share Based Compensation 3,050,000
    • stockholders Equity 78,390,000
    • trading Symbol EYPT
    • update 1970-01-01
    • variable Lease Cost 45,000
    • weighted Average Number Of Diluted Shares Outstanding 37,486,000
    • weighted Average Number Of Shares Outstanding Basic 37,486,000
    • id REPORTED_FINANCIALS
    • key EYPT
    • subkey 10-Q
    • date 2023-05-04
    • updated 2023-05-05
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

EYPT stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0000950170-23-017724
  • accounts Payable Current 9,453,000
  • accumulated Other Comprehensive Income Loss Net Of Tax 843,000
  • allocated Share Based Compensation Expense 3,050,000
  • amendment Flag false
  • assets 154,593,000
  • assets Current 146,057,000
  • cash And Cash Equivalents At Carrying Value 105,765,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 105,915,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 10,132,000
  • cik 1,314,102
  • city Area Code (617)
  • common Stock Par Or Stated Value Per Share 0.001
  • common Stock Shares Authorized 300,000,000
  • common Stock Shares Issued 34,301,926
  • common Stock Shares Outstanding 34,301,926
  • comprehensive Income Net Of Tax --21,107,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-04
  • depreciation 105,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic -0.56
  • earnings Per Share Diluted -0.56
  • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized 11,900,000
  • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 P1Y8M12D
  • entity Address Address Line 1 480 Pleasant Street
  • entity Address City Or Town Watertown
  • entity Address Postal Zip Code 2,472
  • entity Address State Or Province MA
  • entity Central Index Key 1,314,102
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 000-51122
  • entity Filer Category Non-accelerated Filer
  • entity Incorporation State Country Code DE
  • entity Interactive Data Current Yes
  • entity Name EyePoint Pharmaceuticals, Inc.
  • entity Registrant Name EyePoint Pharmaceuticals, Inc.
  • entity Shell Company false
  • entity Small Business true
  • entity Tax Identification Number 26-2774444
  • increase Decrease In Contract With Customer Liability --255,000
  • increase Decrease In Inventories 1,185,000
  • interest Expense 812,000
  • interest Paid Net 740,000
  • inventory Net 4,071,000
  • irs Number 262,774,444
  • lessee Operating Lease Liability Payments Due 7,570,000
  • lessee Operating Lease Liability Payments Due Next Twelve Months 1,392,000
  • lessee Operating Lease Liability Payments Due Year Four 1,637,000
  • lessee Operating Lease Liability Payments Due Year Three 1,589,000
  • lessee Operating Lease Liability Payments Due Year Two 1,494,000
  • lessee Operating Lease Liability Undiscounted Excess Amount 1,095,000
  • liabilities 76,203,000
  • liabilities And Stockholders Equity 154,593,000
  • liabilities Current 27,242,000
  • local Phone Number 926-5000
  • long Term Debt Maturities Repayments Of Principal In Next Twelve Months 9,167,000
  • long Term Debt Maturities Repayments Of Principal In Year Four 833,000
  • long Term Debt Maturities Repayments Of Principal In Year Three 10,000,000
  • long Term Debt Maturities Repayments Of Principal In Year Two 10,000,000
  • long Term Debt Noncurrent 29,370,000
  • marketable Securities Current 16,700,000
  • net Cash Provided By Used In Financing Activities --5,119,000
  • net Cash Provided By Used In Investing Activities 32,086,000
  • net Cash Provided By Used In Operating Activities --16,835,000
  • net Income Loss --21,164,000
  • nonoperating Income Expense 390,000
  • operating Expenses 29,237,000
  • operating Income Loss --21,554,000
  • operating Lease Liability 6,475,000
  • operating Lease Liability Current 754,000
  • operating Lease Liability Current Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
  • operating Lease Liability Noncurrent 5,721,000
  • operating Lease Payments 145,000
  • operating Lease Right Of Use Asset 5,777,000
  • other Assets Current 0
  • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 57,000
  • other Liabilities Current 772,000
  • other Liabilities Noncurrent 600,000
  • other Nonoperating Income Expense 1,202,000
  • payments Related To Tax Withholding For Share Based Compensation 169,000
  • payments To Acquire Property Plant And Equipment 484,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • proceeds From Issuance Of Long Term Debt 0
  • property Plant And Equipment Net 2,609,000
  • repayments Of Long Term Debt 0
  • report Link https://www.sec.gov/Archives/edgar/data/1314102/000095017023017724/eypt-20230331_htm.xml
  • research And Development Expense 13,618,000
  • retained Earnings Accumulated Deficit --692,515,000
  • revenue From Contract With Customer Excluding Assessed Tax 7,683,000
  • share Based Compensation 3,050,000
  • stockholders Equity 78,390,000
  • trading Symbol EYPT
  • update 1970-01-01
  • variable Lease Cost 45,000
  • weighted Average Number Of Diluted Shares Outstanding 37,486,000
  • weighted Average Number Of Shares Outstanding Basic 37,486,000
  • id REPORTED_FINANCIALS
  • key EYPT
  • subkey 10-Q
  • date 2023-05-04
  • updated 2023-05-05